Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report.
Saved in:
| Title: | Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report. |
|---|---|
| Authors: | Vondrák, K.1, Seeman, T.1,2 tomas.seeman@lfmotol.cuni.cz |
| Source: | Transplantation Proceedings. Apr2018, Vol. 50 Issue 3, p967-970. 4p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00411345 |
|---|---|
| DOI: | 10.1016/j.transproceed.2018.02.012 |
